Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

An Identity Crisis for RA

R. Franklin Adams, MD  |  Issue: August 2011  |  August 1, 2011

In sum, I believe that we have not adequately prepared the public for the potential calamity of developing RA. Regrettably, the disease has very little identity unto its own. Despite all the good efforts and intentions of the ACR and the AF, the average individual still has very little appreciation for the vast differences between the two polar opposites: osteoarthritis (OA) and RA. There is no sense of proportionality between the two, no perspective. Only those stricken with the latter quickly learn to distinguish it from the former, the hard way.

Despite the numerous advances in treating rheumatic diseases over the past few decades, a major communication gap still exists regarding the complexity and gravity of rheumatic diseases.

Nomenclature

Confusion of nomenclature remains, in large part, for this failure of insight. Surely, at some point, we should admit mission: impossible! The current classification is simply too archaic and uninformative to expect nonprofessionals to comprehend. Its one thing to teach medical students to distinguish between OA and RA, but its quite another to expect the media or the public to “get it.” It’s past time that we should consider making changes for the sake of clarity for both our patients and the public.

Verbiage and nomenclature certainly do matter. Recently, one of my more erudite golfing buddies asked me (with only a bit of tongue in cheek), “What is it you rheuma-tologists study, phlegm?”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We must face the reality that anything with “arthritis” as part of its name is likely to be relegated to a second tier of human suffering. And, as aforementioned, adding the prefix “rheumatoid” frequently adds little additional impact or insight. Looking back, I believe humanity would have been better served had our forefathers originally designated RA as “rheumatic arthritis” rather than “rheumatoid” (i.e., rheumatic-like) to distinguish it from rheumatic fever. The “rheumatic” connotation would imply a more dynamic and potentially serious illness and would have better distinguished it from OA. “Rheumatoid” sounds indolent, retiring, and yes, more like “rheumatism.”

A Humble Suggestion

As an initial salvo towards better understanding for all, I suggest it is time for some simple, but significant, name changes. The current nomenclature is simply too arcane and misleading. We are using 18th century nomenclature for 21st century bioscience. We are dealing with catastrophic disease here, under the guise of “rheumatism.” It just doesn’t make good sense, and I feel is no longer appropriate.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:ConditionsPractice SupportQuality Assurance/ImprovementRheumatoid Arthritis Tagged with:AC&RDiagnosisPainpatient careRheumatoid Arthritis (RA)Treatment

Related Articles

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

    2017 ACR/ARHP Honors & Awards, Part 2

    January 19, 2018

    SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting in San Diego in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the ARHP winners about their individual contributions. In addition, we profile the new class…

    The 2019 ACR Award Winners & Distinguished Fellows

    December 18, 2019

    ATLANTA—Every year at its Annual Meeting, the ACR recognizes its members’ outstanding contributions to the field of rheumatology through an awards program. The ACR is proud to announce 20 award recipients for 2019, honored for their accomplishments as clinicians, instructors or researchers who have helped advance rheumatology, for their commitment to inspire others to enter…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences